Press Room

DDL 2019

Start
Wednesday, December 11, 2019 - 09:00
End
Friday, December 13, 2019 - 18:00
Location: Edinburgh, Scotland
Booth Number: 239

 

If you would like to find more about Hovione's full range of inhalation development servicesparticle engineering and development by design schedule a meeting with usour colleague Marcel Hogerheide will be pleased to meet with you.

Marcel Hogerheide  | Hovione

Marcel Hogerheide

Head of Account Management & Business Development

 

Schedule a meeting button | Hovione

 

Hovione will present a set of 3 posters:

1. Commercial scale dosator-based capsule filling: the effect of process parameters on the aerodynamic performance of a carrier-based DPI
Poster Board 21
Author: Maria Braga

2. Nasal powder delivery: a step towards a biorelevant dissolution system
Poster Board 34
Author: Patrícia Henriques

3. Aerodynamic performance and imaging characterization of DPI formulations
Poster Board 43
Author: Rúben Chaves

4. Biorelevant dissolution to differentiate formulation performance for inhalation
Poster Board 58
Author: Beatriz Fernandes

 

 

Find here more details about the conference

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025